EDITORIAL SECTIONS
RESEARCH & DEVELOPMENT
Adopting the Power of AI to Drug Development Projects
A tremendous amount of documentation is created throughout the clinical trial lifecycle
CLINICAL TRIALS
Real-world Evidence
Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA
MANUFACTURING
Just in Time Manufacturing Creating more sustainable supply chains
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Information Technology
Challenges and Advantages of Using Artificial Intelligence in Pharma
Many advanced largescale AI initiatives still need to be proved successful in Pharma
KNOWLEDGE BANK
Interviews
Innovation Management at Bachem
Chief Technology Officer, Bachem Holding AG
Gnther Loidl joined Bachem in He held several functions in Research and Development RD and Active Pharmaceutical Ingredient Manufacturing and became Vice President RD in Since he is CTO of the Bachem Group and a member of the Corporate Executive Committee He studied chemistry in Regensburg Germany and Leeds UK and obtained his doctorate under the supervision of Luis Moroder at the Max Planck In...
Research Insights
Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium
Biopharmaceutical products BPs are widely used to treat autoimmune diseases but immunogenicity limits their efficacy for an important proportion of patients Our knowledge of patientrelated factors influencing the occurrence of antidrug antibodies ADAs is still limited
Case Studies
Case Study: Has The Increase In The Availability Of Generic Drugs Lowered The Price Of Cardiovascular Drugs In South Africa?
Abstract The aim of this study was to examine the relationship between originator drug pricing and the number of available generic brands within the cardiovascular drug class in the context of SEP legislation and to compare South African drug prices with international drug prices Background
Techno Trends
New Simoa® phospho-Tau 181 (pTau-181) Blood Test Discovered for Alzheimer’s Disease
Quanterix Corporation discovers new BloodBased pTau Assay for Alzheimers Disease The Simoa phosphoTau pTau blood test will be used for diagnostic evaluation of Alzheimers Disease AD With the use of HDX immunoassay system the pTau concentration in human serum
White Papers
Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches
In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS
TOP ARTICLES
Artificial Intelligence
Assistant Professor, Department of Pharmaceutics, L. M.College of Pharmacy
L. M.College of Pharmacy
The Past, Present, and Future of Sickle-cell Disease Registries: Findings from a Global Review
Sam is an Associate Director in Patient-Centered Research at Vitaccess, providing direction and oversight across their health economics and outcomes research, patient-centered outcomes, and real-world evidence portfolio. Sam joined Vitaccess in 2018, after spending three years as a project manager within the PCO group at a leading contract research organisation.
Fatemeh is a Medical Writer at Vitaccess. She plays a key role in their digital real-world evidence studies, developing materials that range from client-facing deliverables through to content communicating the value and progress of studies to clinical experts, patient representatives, and participants.
Oktawia is a Research Associate at Vitaccess, contributing to their patient-reported outcomes and clinical outcome assessment projects and supporting the development, effective delivery, and quality of their real-world studies. Oktawia has experience in health research from previous roles involving healthcare technologies, a medical ventures accelerator, and her doctoral research studies.
Akosua is an Associate Consultant at Vitaccess, currently project managing a range of their longitudinal and cross-sectional real-world evidence studies. She has experience in developing evidence-generation strategies for clients, including gap analyses for health technology assessment submissions and the reimbursement of digital health technologies.
Blockchain for Data Integrity in Biopharma
Reshma Kodumuru is a Computer System Validation (CSV) leader at KBI Biopharma with expertise in data integrity and regulatory compliance. She specialises in designing and implementing validation frameworks that enhance operational efficiency within the biopharmaceutical industry, bridging complex data systems with strategic, compliant, and effective business solutions.
The Green Revolution in Medicine
Dr Aishwarya Jain is an Assistant Professor and award-winning pharmaceutical researcher recognised with over 70+ national and international honours. Her research focuses on green synthesis, nanotechnology, and sustainable drug delivery. A SCOPUS journal editor and published author, she is dedicated to advancing eco-friendly pharmaceutical innovation and inspiring the next generation of researchers.
Homeopathic Science
Aditya Dilipkumar Patil pursed B.H.M.S. and MD (Hom) from Bharati Vidyapeeth (Deemed to be University) Homoeopathic Medical College and Post Graduate Research Centre, Pune. He is currently working as Assistant Professor in Department of Homoeopathic Pharmacy at Dr.D.Y.Patil Homoeopathic Medical College and Research Centre, Pimpri, Pune 411018. He is a member of Chandrabhaga Charitable trust since 2017 and Life member of Moredada Charitable Trust, Nashik, Department of Herbal Medicine since 2018. He was working as Senior Research Fellow in Central Council for Research in Homoepathy (CCRH under Ministry of AYUSH). His main research work focuses on Evidenced based medicine, Diabetes, preclinical studies (In-vitro & In-vivo), nanoparticle etc.
Parth Sanjeev Aphale pursed B.H.M.S. from Dhondumama Sathe Homoeopathic Medical College and Research Centre, Pune and MD (Hom) from Foster Development Homoeopathic Medical College, Aurangabad. He is currently working as Professor in Department of Homoeopathic pharmacy at Dr.D.Y.Patil Homoeopathic Medical College and Research Centre, Pimpri, Pune 411018.
Dharmendra Basudeo Sharma pursed B.H.M.S. from Dhondumama Sathe Homoeopathic Medical College and Research Centre, Pune and MD (Hom) from University of Rajasthan and Ph.D from Maharashtra University of Health Science (MUHS). He is currently working as Principal and Head of Institute at Dr.D.Y.Patil Homoeopathic Medical College and Research Centre, Pimpri, Pune 411018.
press releasesRead more...
Ractigen Therapeutics Closes Over $31 Million Financing to Advance Clinical-Stage saRNA Pipeline and Proprietary Extrahepatic Delivery Platforms
Ractigen Therapeutics a clinicalstage biotechnology company pioneering small activating RNA saRNA therapeutics and advanced extrahepatic delivery systems today announced the successful closing of a new financing round exceeding million over RMB million
Insilico Medicine Launches the Industry's First Drug Discovery and Development (DDD) Benchmark as a Service, to Evaluate Frontier AI and Foundation Models on Real-World Science
As generalpurpose and domainspecific AI models rapidly infiltrate drug discovery one critical question looms over the pharmaceutical sector Can these models actually discover drugs or are they just good at taking tests
HKEY-AI2Vivo™ 1.0: HKeyBio Accelerates In Vivo Translation for AI-Designed Candidates
HKeyBio has established HKEYAIVivo its AI Candidate In Vivo Validation Acceleration Program The program supports AI drugdiscovery teams in translating AIgenerated targets
Medidata Launches Medidata Plus, an AI-Native Foundation Built to Scale Clinical Portfolios
Medidata a Dassault Systmes brand and leading provider of clinical trial solutions today announced the launch of Medidata Plus This clinical artificial intelligence layer unlocks the full breadth of AI capabilitie
Insilico Medicine Receives FDA Fast Track Designation for ISM6331, the AI-driven Pan-TEAD Inhibitor, in Advanced Mesothelioma
Insilico Medicine Insilico HKEX a clinicalstage generative artificial intelligence AIdriven drug discovery company today announced that ISM a novel potential bestinclass panTEAD inhibitor driven
Elix, an AI Drug Discovery Company and University of Vienna Enter into Joint Research Agreement to Advance Drug Discovery Using AI Technology
Elix Inc and University of Vienna Austria represented by the Dean of the Faculty of Life Sciences Prof Mag Dr KarlHeinz Wagner hereinafter U Vienna are pleased to announce the signing of a joint research agreement aimed
EventsRead more...
03 - 04
Aug 2026Clinical Pharmacology and Toxicology 2026
Dubai, UAE
11 - 12
Aug 2026Medical Device Safety Monitoring and Reporting
San Diego, CA, USA
19 - 21
Aug 2026ISPE Singapore Conference & Exhibition 2026
Suntec Singapore
20 - 21
Aug 2026Pharmaceutical Formulations 2026
London, UK
20 - 21
Aug 2026Novel Drug Delivery Systems 2026
London, UK
20 - 21
Aug 2026Advanced Clinical Research 2026
London, UK
25 - 27
Aug 2026CPHI Korea 2026
COEX, Seoul, Korea
26 - 27
Aug 2026BIOMEDevice 2026
Boston Convention & Exhibition...
LATEST NEWSRead more...
Kaigene Licenses Autoimmune Therapy KG006 to Taisho Pharmaceutical for Japan
Kaigene a USbased biotechnology company focused on antibody therapies for autoimmune diseases has signed an exclusive licensing agreement with Taisho Pharmaceutical for the development and commercialisation of its nextgeneration human neonatal Fc receptor hFcRn inhibitor
EVERSANA to Support US Commercialisation of Innovacell’s ICEF15 Cell Therapy
EVERSANA has been selected by Tokyobased biotechnology company Innovacell as its exclusive commercialisation partner in the United States to support the planned launch of ICEF a regenerative cell therapy for urgent faecal incontinence
Ember LifeSciences and Alfresa Form Strategic Alliance to Strengthen Pharmaceutical Cold Chain in Japan
Ember LifeSciences has entered into a capital and business alliance with Alfresa Corporation to enhance pharmaceutical cold chain logistics in Japan As part of the agreement
AbCellera and Vertex Partner to Develop Multispecific T-Cell Engagers for Autoimmune Diseases
AbCellera has entered into a collaboration with Vertex Pharmaceuticals to discover develop manufacture and commercialise multispecific Tcell engagers TCEs for the treatment of autoimmune
Shionogi Launches XOCOVA in the U.S. for Prevention of COVID-19 Following Exposure
Shionogi has announced the US availability of XOCOVA ensitrelvir the first and only oral antiviral approved to help prevent COVID after exposure The treatment is indicated for adults and adolescents aged years
DKSH Korea Expands Partnership with Novartis to Strengthen Hypertension Portfolio
DKSH Healthcare has expanded its strategic partnership with Novartis in South Korea by adding the hypertension medicines Diovan and Exforge to its prescription drug portfolio Under the agreement